Held the third Friday of every month in BRB 701 at noon. Two trainees present their research findings each month. The 2022 - 2023 schedule is as follow September 16, 2022 / Presentations
► June Yang, Dr. J. You lab presenting Determining the cellular factors regulating Merkel cell polyomavirus transcription► Dipayan Bose from Dr. E. Robertson Lab presents KSHV mediated protection of cellular RNA Polymerase II during hypoxia
October 21, 2022 / Presentations
► Alex Price, Dr. M. Weitzman Lab presenting "Novel viral open reading frames revealed by long-read direct RNA sequencing of adenovirus transcripts".
Wei Liu, Dr. J. You Lab, scheduled but not presented
November 18, 2022 / Presentations
► Joangela Nouel, Dr. E. White Lab, presenting "ZER1 contributes to the carcinogenic activity of high-risk HPV E7 proteins".
December 16, 2022 / Presentations
► Chenhe Su, Dr. P. Lieberman Lab, presenting "Increased Lytic Activity and Inflammation in Spontaneous Lymphoblastoid Cell Lines derived from MS Patients".
January 20, 2023 / Presentations
► Malay Sannigrahi, Dr. D. Basu Lab, presenting "Analysis of targetable gene dependencies identifies PAK2 as a novel target in HPV-negative head and neck squamous cell carcinomas".
Amulya Sreekumar, Dr. L. Chodosh Lab, scheduled but not presented
February 17, 2023 / Presentations
► William Blakely, Dr. E. White Lab, presenting "HPV18 E7 activates oncoprotein YAP1 by promoting PTPN14 degradation".
► Leonardo Castro Muñoz, Dr. P. Lieberman Lab, presenting "Histone Variants and Histone Modifications Regulating Epstein–Barr virus Latency".► Namrata Kumar, Dr. M. Weitzman Lab "Herpes simplex virus manipulates cellular DNA repair pathways for productive infection".
April 21, 2023 / Presentations
► Taylor Senay, Dr. J. You Lab, presenting "Determining the Role of MCPyV ALTO in Modulating Host Immunity".► Devivasha Bordoloi, Dr. D. Weiner Lab, presenting "Novel Siglec-7 biologics for targeted cancer immunotherapy".
May 19, 2023 / Presentations
Amy Gladstein, Dr D. Feldser Lab, presented "The tumor suppressive role(s) of Setd2 in lung cancer".
Ryan O'Connell, Dr. D. Weiner Lab, presented "Development of novel bispecific T cell engagers for the immune targeting of carbonic anhydrase 9 in renal cell carcinoma".